Skip to main content

Table 3 IRs and HRs for mortality, CAD, stroke, and HF hospitalization

From: Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes

Outcomes

AGI

Case vs. control

No

Yes

Crude HR

Adjusted HR

Event

Person Years

IR

Event

Person Years

IR

(95% CI)

(95% CI)

CV death

54

20,529

2.63

59

20,654

2.86

1.10 (0.76–1.60)

1.20 (0.83–1.74)

Non-CV death

259

20,529

12.62

314

20,654

15.20

1.21 (1.02–1.42)*

1.27 (1.07–1.50)**

Hospitalized CAD

295

20,511

14.38

332

20,563

16.15

1.12 (0.96–1.31)

1.12 (0.95–1.31)

Hospitalized stroke

358

20,332

17.61

354

20,533

17.24

0.98 (0.85–1.13)

0.98 (0.85–1.14)

Hospitalized HF

281

20,042

14.02

288

20,081

14.34

1.02 (0.87–1.21)

1.03 (0.87–1.22)

  1. Adjusted HR was adjusted for sex, age, urbanization, and all comorbidities in Cox proportional hazards regression
  2. IR Incidence rate (per 1000 person-years), HR Hazard ratio, CI Confidence interval, CV Cardiovascular death, CAD Coronary artery disease, HF Heart failure
  3. *p < 0.05, **p < 0.01